The Juvenile Idiopathic Arthritis (JIA) Susceptibility Locus, IL2RA, Includes An Intronic Enhancer That Is Attenuated By JIA-Associated Genetic Variants

Like most rheumatic diseases, genetic risk loci for juvenile idiopathic arthritis (JIA) are highly enriched for H3K4me1/H3K27ac histone marks, epigenetic signatures often associated with enhancer function. We sought to determine whether an H3K4me1/H3K27ac region of the JIA risk locus, IL2RA exhibits enhancer function and whether enhancer function is altered by JIA-associated genetic variants. We used a conventional luciferase reporter assay to query enhancer function across an H3K4me1/H3K27ac-marked region within the first intron of the IL2RA gene. We used the same approach to query the effects of 4 single nucleotide polymorphisms (SNPs) on enhancer function. We identified a 657 base pair region within the first intron of IL2RA that demonstrated brisk enhancer function. Enhancer activity was observable in both Jurkat T cells and myeloid HL60 cells. We identified 2 genetic variants, rs117119468 (C->T), and rs12722502 (C->T), that attenuated enhancer activity in this 657 bp region. Conclusions – The JIA-associated risk locus, IL2RA, contains at least one functional enhancer that is active in both lymphoid and myeloid cells. We identified 2 genetic variants that attenuate activity of this enhancer, making them strong candidates as causal variants.